Human trials of the combination vaccine are expected to start later this year.Vaccine specialistNovavax(NASDAQ: NVAX) plans to file for an emergency use authorization with the Food and Drug Administration for its COVID-19 vaccine candidate in July. In addition, the biotech's vaccine candidate for ...

https://www.fool.com/investing/2021/05/12/novavax-reports-positive-data-from-animal-trial-of/?source=iedfolrf0000001

#fool